HIGHLIGHTS
- who: Debopam Samanta from the Child Neurology Section, Department of Pediatrics, University of Arkansas for Medical Sciences, Children's have published the research work: Fenfluramine: A Review of Pharmacology, Clinical Efficacy, and Safety in Epilepsy, in the Journal: Children 2022, 9, 1159. of /2022/
- what: The analysis showed that 58-60% of patients never reached baseline seizure numbers over the entire trial period . The primary reason for discontinuation was lack of efficacy (22%).
- future: Studies are needed to understand FFA's interaction with other commonly used ASMs such as lamotrigine rufinamide and topiramate . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.